Log In
BCIQ
Print this Print this
 

Doxorubicin

  Manage Alerts
Collapse Summary General Information
Company Capsulution Pharma AG
DescriptionNanoparticle doxorubicin formulation
Molecular Target Topoisomerase II (TOP2)
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat brain cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today